Eastern Company
F:EAQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eastern Company
F:EAQ
|
US |
|
S
|
Super Turtle PCL
SET:TURTLE
|
TH |
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
IL |
|
M&T Bank Corp
NYSE:MTB
|
US |
|
Z
|
Zinitix Co Ltd
KOSDAQ:303030
|
KR |
|
WhiteHorse Finance Inc
NASDAQ:WHF
|
US |
|
I
|
IRPC PCL
SET:IRPC
|
TH |
|
eFFECTOR Therapeutics Inc
OTC:EFTR
|
US |
|
S
|
SGF Capital PCL
SET:SGF
|
TH |
|
Helen of Troy Ltd
NASDAQ:HELE
|
BM |
|
M
|
MoonLake Immunotherapeutics
NASDAQ:MLTX
|
CH |
|
Castillo Copper Ltd
ASX:CCZ
|
AU |
|
E
|
Evrofarma SA
ATHEX:EVROF
|
GR |
|
R
|
Rocca SA
WSE:RCA
|
PL |
Wall Street
Price Targets
EAQ Price Targets Summary
Eastern Company
According to Wall Street analysts, the average 1-year price target for EAQ is 28.44 EUR with a low forecast of 28.16 EUR and a high forecast of 29.27 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EAQ's stock price target?
Price Target
28.44
EUR
According to Wall Street analysts, the average 1-year price target for EAQ is 28.44 EUR with a low forecast of 28.16 EUR and a high forecast of 29.27 EUR.
What is Eastern Company's Revenue forecast?
Projected CAGR
19%
For the last 14 years the compound annual growth rate for Eastern Company's revenue is 4%. The projected CAGR for the next 1 year is 19%.
What is Eastern Company's Operating Income forecast?
Projected CAGR
8%
For the last 14 years the compound annual growth rate for Eastern Company's operating income is 6%. The projected CAGR for the next 1 year is 8%.
What is Eastern Company's Net Income forecast?
Projected CAGR
119%
For the last 14 years the compound annual growth rate for Eastern Company's net income is 2%. The projected CAGR for the next 1 year is 119%.
